Gamida Cell Announces the Date of Its Third Quarter 2019 Financial Results and Webcast
BOSTON--(BUSINESS WIRE)--Nov 5, 2019--
Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the company will host a conference call and live audio webcast on Wednesday, November 13, 2019, at 4:30 p.m. ET to review its third quarter 2019 financial results and provide an update on the company.
The webcast will be available on the “Investors” section of the Gamida Cell website at www.gamida-cell.com. To participate in the live call, please dial 866-930-5560 (domestic) or 409-216-0605 (international) and refer to conference ID number 8653335. A replay of the webcast will be available approximately two hours after the event, for approximately 30 days.
About Gamida Cell
Gamida Cell is a clinical-stage biopharmaceutical company committed to developing advanced cell therapies with the potential to cure blood cancers and rare, serious hematologic diseases. We are leveraging our proprietary nicotinamide-based, or NAM-based, cell expansion platform to develop product candidates designed to expand the possibility of cell therapy. For additional information, please visit www.gamida-cell.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191105005071/en/
CONTACT: Jaren Irene Madden
KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL ONCOLOGY
SOURCE: Gamida Cell Ltd.
Copyright Business Wire 2019.
PUB: 11/05/2019 08:31 AM/DISC: 11/05/2019 08:31 AM